KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $11,075,000 | +129.9% | 61,593 | +32.5% | 0.08% | +110.5% |
| Q2 2017 | $4,818,000 | +1950.2% | 46,474 | +1449.1% | 0.04% | +1800.0% |
| Q1 2017 | $235,000 | -5.6% | 3,000 | -39.8% | 0.00% | 0.0% |
| Q2 2016 | $249,000 | -90.0% | 4,981 | -87.7% | 0.00% | -92.3% |
| Q4 2015 | $2,496,000 | – | 40,504 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|